Nifty

:

24287.65

Sensex

:

77728.16

-78.35 (-0.32%)
-281.09 (-0.36%)

Login

Nifty
Sensex

:
:

24287.65
77728.16

-78.35 (-0.32%)
-281.09 (-0.36%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

70/99

BSE: 500660 | NSE: GLAXO

Watchlist

NSE BSE

2702.90

17-Aug-2026

Open
High
Low
Previous Close

2688
2710
2660
2688.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

84337
227585577.1
2883.4
2088.1

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

45,736.24
42.82
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

44,345.22
2.11%
18.15

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.77
3.12
3.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.07
11.44
7.58

PAT CAGR (%)

10 Years
5 Years
3 Years

11.89
22.16
20.65

P:E (Median)

8 Years
5 Years
3 Years

54.17
48.78
51.52

P:BV (Average)

8 Years
5 Years
3 Years

17.01
19.07
22.03

EV:EBITDA (Average)

8 Years
5 Years
3 Years

31.92
30.67
33.63

Earnings Forecasts:

(Updated: 15-08-2026)

Description 2026 2027 2028 2029
Adj EPS 48 -16 11.72 61.86
P/E Ratio 56.31 -168.93 230.62 43.69
Revenue 35.56 31.29 29.4 3888.93
EBITDA 4193.93 4645.3 5025.1 1339.33
Net Income 1464.38 1667.15 1770.5 1050.8
ROA 1151.75 1309.45 - 35.88
P/B Ratio -0.87 -0.72 - 19.02
ROE 15.11 12.71 - 46.24
FCFF 43.4 41.18 36.45 407.9
FCFF Yield 942.75 1329.13 60.35 1.07
Net Debt 2.47 3.48 0.16 -2434.35
BVPS -3113.3 -3756.2 - 142.14

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 924.42 804.83 14.86% 989.15 966.08 2.39% 1,022.59 946.36 8.06% 973.63 1,000.05 -2.64%
Expenses 631.26 554.08 13.93% 641.96 635.34 1.04% 655.01 656.18 -0.18% 638.95 681.10 -6.19%
EBITDA 293.16 250.75 16.91% 347.19 330.74 4.97% 367.58 290.18 26.67% 334.68 318.95 4.93%
EBIDTM 31.71% 31.16% 35.10% 34.24% 35.95% 30.66% 34.37% 31.89%
Other Income 61.63 43.76 40.84% 35.71 39.46 -9.50% 31.82 35.06 -9.24% 31.27 32.19 -2.86%
Interest 0.97 0.42 130.95% 0.61 0.58 5.17% 1.19 0.09 1,222.22% 0.51 0.27 88.89%
Depreciation 15.84 15.52 2.06% 13.17 14.72 -10.53% 20.32 18.80 8.09% 17.43 16.86 3.38%
PBT 337.98 278.57 21.33% 369.12 354.90 4.01% 377.89 306.35 23.35% 350.65 338.70 3.53%
Tax 84.65 73.87 14.59% 94.18 94.76 -0.61% 100.71 77.77 29.50% 95.65 90.01 6.27%
PAT 253.33 204.70 23.76% 274.94 260.14 5.69% 277.18 228.58 21.26% 255.00 248.69 2.54%
PATM 27.40% 25.43% 27.80% 26.93% 27.11% 24.15% 26.19% 24.87%
EPS 14.95 12.08 23.76% 16.23 15.36 5.66% 16.36 13.49 21.28% 15.05 14.68 2.52%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 938.44 805.17 16.55% 995.30 974.37 2.15% 1,041.26 949.42 9.67% 979.94 1,010.77 -3.05%
Expenses 642.94 553.97 16.06% 644.37 641.18 0.50% 669.92 657.50 1.89% 644.21 689.06 -6.51%
EBITDA 295.50 251.20 17.64% 350.93 333.19 5.32% 371.34 291.92 27.21% 335.73 321.71 4.36%
EBIDTM 31.49% 31.20% 35.26% 34.20% 35.66% 30.75% 34.26% 31.83%
Other Income 43.76 43.72 0.09% 35.95 40.68 -11.63% 32.12 35.07 -8.41% 33.57 34.54 -2.81%
Interest 0.97 0.42 130.95% 0.61 0.58 5.17% 1.19 0.09 1,222.22% 0.51 0.27 88.89%
Depreciation 15.84 15.52 2.06% 13.17 14.72 -10.53% 20.32 18.80 8.09% 17.43 16.86 3.38%
PBT 322.45 278.98 15.58% 373.10 358.57 4.05% 399.93 308.10 29.81% 354.00 343.81 2.96%
Tax 85.27 73.97 15.28% 95.24 95.70 -0.48% 104.31 78.22 33.35% 96.51 91.31 5.69%
PAT 237.18 205.01 15.69% 277.86 262.87 5.70% 295.62 229.88 28.60% 257.49 252.50 1.98%
PATM 25.27% 25.46% 27.92% 26.98% 28.39% 24.21% 26.28% 24.98%
EPS 14.00 12.10 15.70% 16.40 15.52 5.67% 17.45 13.57 28.59% 15.20 14.90 2.01%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 3,909.79 3,790.20 3,723.49 3,407.25 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53 2,871.69 2,902.99 Net Sales Growth 5.18% 1.79% 9.28% 5.94% -0.04% 10.17% -9.43% 3.07% 8.94% -1.08% Cost Of Goods Sold 1,352.49 1,324.02 1,367.19 1,288.43 1,250.03 1,295.74 1,249.37 1,307.87 1,353.53 1,240.75 1,393.77 Gross Profit 2,557.30 2,466.19 2,356.29 2,118.82 1,966.32 1,921.77 1,671.11 1,916.81 1,775.01 1,630.93 1,509.22 GP Margin 65.41% 65.07% 63.28% 62.19% 61.14% 59.73% 57.22% 59.44% 56.74% 56.79% 51.99% Total Expenditure 2,567.18 2,490.00 2,554.20 2,506.60 2,416.92 2,461.68 2,322.70 2,566.23 2,522.05 2,363.25 2,483.05 Power & Fuel Cost - 30.36 30.18 29.64 29.60 27.83 26.08 33.36 27.94 26.44 27.82 % Of Sales - 0.80% 0.81% 0.87% 0.92% 0.86% 0.89% 1.03% 0.89% 0.92% 0.96% Employee Cost - 607.25 579.70 624.39 594.99 610.23 616.16 628.55 537.20 523.40 483.01 % Of Sales - 16.02% 15.57% 18.33% 18.50% 18.97% 21.10% 19.49% 17.17% 18.23% 16.64% Manufacturing Exp. - 101.49 114.26 113.61 99.05 120.14 110.59 107.88 115.19 110.55 108.26 % Of Sales - 2.68% 3.07% 3.33% 3.08% 3.73% 3.79% 3.35% 3.68% 3.85% 3.73% General & Admin Exp. - 163.05 194.11 190.48 189.33 143.99 117.27 164.31 178.51 203.43 194.72 % Of Sales - 4.30% 5.21% 5.59% 5.89% 4.48% 4.02% 5.10% 5.71% 7.08% 6.71% Selling & Distn. Exp. - 203.15 189.84 184.22 180.97 199.59 124.73 212.36 202.81 154.38 178.88 % Of Sales - 5.36% 5.10% 5.41% 5.63% 6.20% 4.27% 6.59% 6.48% 5.38% 6.16% Miscellaneous Exp. - 60.68 78.91 75.82 72.95 64.17 78.51 111.89 106.88 104.29 178.88 % Of Sales - 1.60% 2.12% 2.23% 2.27% 1.99% 2.69% 3.47% 3.42% 3.63% 3.33% EBITDA 1,342.61 1,300.20 1,169.29 900.65 799.42 755.83 597.78 658.45 606.48 508.44 419.94 EBITDA Margin 34.34% 34.30% 31.40% 26.43% 24.85% 23.49% 20.47% 20.42% 19.39% 17.71% 14.47% Other Income 160.43 142.56 142.56 123.48 101.51 76.22 110.19 77.56 101.48 53.52 72.01 Interest 3.28 2.73 1.31 1.80 1.81 1.99 3.53 6.34 0.55 0.19 0.25 Depreciation 66.76 66.44 66.79 69.68 65.77 68.19 78.60 82.68 48.59 37.99 26.35 PBT 1,435.64 1,373.59 1,243.74 952.65 833.36 761.87 625.83 646.99 658.82 523.78 465.35 Tax 375.19 364.40 329.39 224.35 227.69 396.87 166.54 212.45 238.35 189.60 174.30 Tax Rate 26.13% 26.48% 26.38% 27.73% 27.35% 51.31% 36.75% 65.88% 35.91% 35.01% 34.10% PAT 1,060.45 1,011.82 919.05 584.69 604.71 376.58 286.69 110.05 425.36 351.99 336.78 PAT before Minority Interest 1,060.45 1,011.82 919.05 584.69 604.71 376.58 286.69 110.05 425.36 351.99 336.78 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 27.12% 26.70% 24.68% 17.16% 18.80% 11.70% 9.82% 3.41% 13.60% 12.26% 11.60% PAT Growth 12.56% 10.09% 57.19% -3.31% 60.58% 31.35% 160.51% -74.13% 20.84% 4.52% EPS 62.60 59.73 54.25 34.52 35.70 22.23 16.92 6.50 25.11 20.78 19.88

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 3,954.94 3,821.67 3,749.21 3,453.71 3,251.72 3,278.03 2,925.60 3,224.38 3,128.12 2,871.45 2,908.47 Net Sales Growth 5.75% 1.93% 8.56% 6.21% -0.80% 12.05% -9.27% 3.08% 8.94% -1.27% Cost Of Goods Sold 1,391.29 1,351.05 1,390.85 1,334.53 1,284.88 1,356.19 1,256.86 1,307.87 1,358.03 1,241.31 1,397.75 Gross Profit 2,563.65 2,470.62 2,358.35 2,119.18 1,966.85 1,921.84 1,668.75 1,916.51 1,770.09 1,630.14 1,510.72 GP Margin 64.82% 64.65% 62.90% 61.36% 60.49% 58.63% 57.04% 59.44% 56.59% 56.77% 51.94% Total Expenditure 2,601.44 2,512.47 2,571.85 2,545.02 2,447.44 2,516.15 2,327.46 2,567.13 2,527.32 2,365.66 2,489.49 Power & Fuel Cost - 30.36 30.18 29.64 29.60 27.83 26.08 33.36 27.94 26.44 27.82 % Of Sales - 0.79% 0.80% 0.86% 0.91% 0.85% 0.89% 1.03% 0.89% 0.92% 0.96% Employee Cost - 607.25 579.70 624.39 594.99 610.23 616.16 628.55 537.20 523.40 483.01 % Of Sales - 15.89% 15.46% 18.08% 18.30% 18.62% 21.06% 19.49% 17.17% 18.23% 16.61% Manufacturing Exp. - 101.49 114.26 113.61 99.05 120.14 110.59 107.89 115.55 110.55 108.26 % Of Sales - 2.66% 3.05% 3.29% 3.05% 3.67% 3.78% 3.35% 3.69% 3.85% 3.72% General & Admin Exp. - 163.38 194.14 190.50 189.33 144.08 117.31 164.51 178.60 204.45 195.08 % Of Sales - 4.28% 5.18% 5.52% 5.82% 4.40% 4.01% 5.10% 5.71% 7.12% 6.71% Selling & Distn. Exp. - 203.15 189.84 184.22 180.97 199.59 124.73 212.36 202.81 154.38 178.91 % Of Sales - 5.32% 5.06% 5.33% 5.57% 6.09% 4.26% 6.59% 6.48% 5.38% 6.15% Miscellaneous Exp. - 55.79 72.87 68.13 68.62 58.09 75.74 112.58 107.20 105.12 178.91 % Of Sales - 1.46% 1.94% 1.97% 2.11% 1.77% 2.59% 3.49% 3.43% 3.66% 3.39% EBITDA 1,353.50 1,309.20 1,177.36 908.69 804.28 761.88 598.14 657.25 600.80 505.79 418.98 EBITDA Margin 34.22% 34.26% 31.40% 26.31% 24.73% 23.24% 20.45% 20.38% 19.21% 17.61% 14.41% Other Income 145.40 145.36 145.93 122.59 100.66 75.78 110.58 79.01 102.32 54.54 73.07 Interest 3.28 2.73 1.31 1.80 1.81 2.00 3.53 6.34 0.55 0.19 0.25 Depreciation 66.76 66.44 66.79 69.68 65.77 68.19 78.60 82.68 48.59 37.99 26.35 PBT 1,449.48 1,385.39 1,255.19 959.80 837.37 767.47 626.59 647.25 653.97 522.17 465.46 Tax 381.33 370.03 332.30 226.23 228.76 398.28 166.72 212.55 237.28 189.24 174.37 Tax Rate 26.31% 26.32% 26.38% 27.72% 27.35% 51.12% 36.72% 69.52% 34.76% 35.05% 34.11% PAT 1,068.15 1,035.98 927.58 589.96 607.64 380.77 287.27 93.20 445.39 350.73 336.81 PAT before Minority Interest 1,068.15 1,035.98 927.58 589.96 607.64 380.77 287.27 93.20 445.39 350.73 336.81 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 27.01% 27.11% 24.74% 17.08% 18.69% 11.62% 9.82% 2.89% 14.24% 12.21% 11.58% PAT Growth 12.41% 11.69% 57.23% -2.91% 59.58% 32.55% 208.23% -79.07% 26.99% 4.13% EPS 63.05 61.16 54.76 34.83 35.87 22.48 16.96 5.50 26.29 20.70 19.88

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 2,241.17 1,949.23 1,784.09 1,753.00 2,677.62 1,497.12 1,840.04 2,142.42 2,079.95 2,028.21 Share Capital 169.41 169.41 169.41 169.41 169.41 169.41 169.41 169.41 84.70 84.70 Total Reserves 2,087.47 1,794.70 1,623.69 1,585.27 2,508.21 1,327.71 1,670.63 1,973.01 1,995.25 1,943.51 Non-Current Liabilities 143.02 110.25 106.82 124.49 157.84 178.87 180.56 2,835.06 2,572.79 3,639.66 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.18 0.58 0.99 Long Term Provisions 259.36 248.40 246.21 253.55 260.96 258.25 260.49 2,893.17 2,673.01 3,726.49 Current Liabilities 1,757.11 1,900.81 1,510.94 1,317.03 1,674.35 1,319.42 1,002.07 2,800.62 2,945.16 878.32 Trade Payables 549.66 704.01 613.24 418.56 555.45 447.99 354.19 402.96 502.53 275.92 Other Current Liabilities 243.60 255.88 205.60 184.47 503.54 433.09 205.84 802.59 842.33 391.18 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 963.85 940.93 692.10 713.99 615.36 438.35 442.04 1,595.07 1,600.30 211.22 Total Liabilities 4,141.30 3,960.29 3,401.85 3,194.52 4,509.81 2,995.41 3,022.67 7,778.10 7,597.90 6,546.19 Net Block 280.07 282.87 320.36 328.90 329.44 385.56 756.59 429.99 322.81 252.71 Gross Block 716.18 666.70 663.27 633.68 591.65 600.65 1,452.35 559.05 405.89 299.09 Accumulated Depreciation 436.10 383.83 342.91 304.79 262.20 215.09 695.76 129.06 83.08 46.38 Non Current Assets 598.17 576.75 636.01 727.80 839.10 824.08 1,265.90 4,437.17 4,085.73 4,735.48 Capital Work in Progress 32.93 14.32 13.93 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 Non Current Investment 25.36 24.49 24.49 24.49 24.49 24.49 24.49 24.55 47.67 47.67 Long Term Loans & Adv. 258.92 253.87 275.12 351.98 448.04 392.45 356.05 2,970.52 2,785.85 3,817.84 Other Non Current Assets 0.24 0.43 1.22 1.08 5.44 7.03 7.17 7.84 4.75 6.47 Current Assets 3,543.12 3,383.55 2,765.84 2,466.72 3,670.60 1,991.21 1,756.67 3,337.60 3,507.23 1,809.07 Current Investments 1,390.96 1,118.25 813.22 518.29 365.59 0.00 0.00 0.00 0.00 0.00 Inventories 430.35 463.17 514.29 437.70 512.71 523.34 483.03 486.49 500.18 425.48 Sundry Debtors 273.11 292.55 222.06 192.38 205.24 215.60 99.80 120.49 146.96 170.80 Cash & Bank 1,354.79 1,400.89 1,061.20 1,150.73 2,479.11 1,157.68 1,066.41 1,155.33 1,279.69 882.23 Other Current Assets 93.90 82.26 130.39 155.40 107.94 94.58 107.43 1,575.28 1,580.39 330.57 Short Term Loans & Adv. 36.54 26.44 24.68 12.22 28.39 56.48 59.11 1,466.65 1,506.82 226.27 Net Current Assets 1,786.01 1,482.73 1,254.90 1,149.69 1,996.24 671.79 754.60 536.98 562.07 930.76 Total Assets 4,141.29 3,960.30 3,401.85 3,194.52 4,509.70 2,815.29 3,022.57 7,774.77 7,592.96 6,544.55

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 2,267.42 1,951.31 1,777.64 1,741.27 2,662.96 1,478.26 1,820.60 2,139.83 2,057.33 2,006.86 Share Capital 169.41 169.41 169.41 169.41 169.41 169.41 169.41 169.41 84.70 84.70 Total Reserves 2,113.72 1,796.78 1,617.24 1,573.54 2,493.55 1,308.85 1,651.20 1,970.42 1,972.63 1,922.15 Non-Current Liabilities 143.50 110.73 107.72 125.40 158.75 178.68 180.19 2,860.37 2,632.47 3,699.70 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.18 0.58 0.99 Long Term Provisions 260.07 249.11 247.46 254.80 262.21 259.50 261.74 2,920.20 2,733.36 3,786.83 Current Liabilities 1,779.10 1,905.15 1,524.95 1,326.37 1,698.43 1,354.58 1,021.95 2,804.07 2,948.98 881.09 Trade Payables 570.22 708.25 625.41 427.79 579.33 466.13 357.06 405.81 505.86 278.93 Other Current Liabilities 243.74 255.98 207.44 184.59 503.74 450.11 222.85 802.71 842.35 390.47 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 965.14 940.93 692.10 713.99 615.36 438.35 442.04 1,595.54 1,600.77 211.69 Total Liabilities 4,190.02 3,967.19 3,410.31 3,193.04 4,520.14 3,011.52 3,022.74 7,804.27 7,638.78 6,587.65 Net Block 280.07 282.87 320.36 328.90 329.44 385.56 756.59 429.99 322.81 252.71 Gross Block 716.18 666.70 663.27 633.68 591.65 600.65 1,452.35 559.05 405.89 299.09 Accumulated Depreciation 436.10 383.83 342.91 304.79 262.20 215.09 695.76 129.06 83.08 46.38 Non Current Assets 583.82 557.32 611.89 698.77 812.10 808.88 1,247.87 4,445.06 4,103.26 4,752.54 Capital Work in Progress 32.93 14.32 13.93 20.31 30.50 13.21 120.12 1,002.64 922.90 605.46 Non Current Investment 0.87 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.06 0.06 Long Term Loans & Adv. 269.04 258.89 275.44 347.40 445.49 401.71 362.49 3,002.88 2,850.97 3,882.49 Other Non Current Assets 0.26 0.45 1.24 1.10 5.45 7.05 7.17 7.84 4.75 6.47 Current Assets 3,606.20 3,409.88 2,798.42 2,494.26 3,707.92 2,022.52 1,774.77 3,355.88 3,530.59 1,833.48 Current Investments 1,390.96 1,118.25 813.22 518.29 365.59 0.00 0.00 0.00 0.00 0.00 Inventories 457.55 481.74 525.05 459.97 534.70 546.70 483.03 486.49 500.18 425.80 Sundry Debtors 273.11 292.55 222.06 192.38 205.24 215.60 99.80 120.49 146.96 170.80 Cash & Bank 1,391.02 1,403.52 1,063.22 1,155.93 2,484.51 1,157.96 1,083.20 1,171.35 1,296.41 899.61 Other Current Assets 93.55 87.40 150.19 155.48 117.89 102.25 108.74 1,577.56 1,587.03 337.27 Short Term Loans & Adv. 36.54 26.44 24.68 12.22 28.40 56.48 60.27 1,468.58 1,513.25 232.20 Net Current Assets 1,827.09 1,504.73 1,273.47 1,167.89 2,009.49 667.94 752.82 551.82 581.61 952.38 Total Assets 4,190.02 3,967.20 3,410.31 3,193.03 4,520.02 2,831.40 3,022.64 7,800.94 7,633.85 6,586.02

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 881.42 1,280.03 578.94 487.94 819.79 594.87 490.97 411.18 474.77 232.28 PBT 1,373.59 1,243.74 952.65 837.49 2,470.04 722.33 646.99 658.82 523.78 465.35 Adjustment -64.81 -68.98 -46.14 -40.86 -1,636.93 -25.25 14.20 -30.52 -11.15 -45.42 Changes in Working Capital -107.25 186.18 64.55 -39.02 134.89 63.03 43.59 -7.58 163.69 -29.47 Cash after chg. in Working capital 1,201.52 1,360.95 971.06 757.61 968.00 760.11 704.78 620.71 676.33 390.46 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -320.10 -80.93 -252.67 -262.86 -112.15 -146.91 -179.55 -194.15 -201.82 -160.86 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 -139.45 -6.81 -36.06 -18.34 -34.26 -15.38 0.25 2.67 Cash From Investing Activity 385.25 -36.53 14.97 805.19 -419.66 407.57 -63.10 -154.44 -107.01 303.08 Net Fixed Assets -68.09 -3.82 -23.21 -31.84 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 Net Investments -273.58 -305.03 -294.93 -152.70 -365.59 0.00 0.06 23.12 0.00 0.00 Others 726.92 272.32 333.11 989.73 -45.78 -551.04 -52.38 55.34 317.23 711.60 Cash from Financing Activity -737.07 -769.42 -561.50 -1,544.18 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 Net Cash Inflow / Outflow 529.60 474.07 32.41 -251.05 -124.11 306.87 0.25 -101.62 61.12 24.59 Opening Cash & Equivalents 536.22 62.15 29.74 280.79 404.90 98.03 97.78 199.40 138.27 113.68 Closing Cash & Equivalent 1,065.82 536.22 62.15 29.74 280.79 404.90 98.03 97.78 199.40 138.27

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 903.30 1,289.90 582.02 484.23 810.75 577.91 490.50 409.49 472.80 234.37 PBT 1,385.39 1,255.19 959.80 841.49 2,475.65 723.10 647.25 653.97 522.17 465.46 Adjustment -65.25 -68.41 -45.13 -40.00 -1,636.48 -25.64 13.17 -31.36 -12.17 -46.47 Changes in Working Capital -98.17 184.83 61.02 -45.75 119.87 45.75 44.07 -4.19 164.56 -26.69 Cash after chg. in Working capital 1,221.97 1,371.61 975.69 755.75 959.04 743.20 704.49 618.41 674.55 392.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -318.67 -81.71 -254.23 -264.71 -112.23 -146.95 -179.72 -194.24 -202.01 -160.59 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 -139.45 -6.81 -36.06 -18.34 -34.26 -14.69 0.25 2.67 Cash From Investing Activity 396.98 -45.80 8.71 807.85 -405.51 418.03 -56.84 -153.45 -104.19 300.64 Net Fixed Assets -68.09 -3.82 -23.21 -31.84 -8.29 958.61 -10.78 -232.90 -424.24 -408.52 Net Investments -273.58 -305.03 -294.93 -152.70 -365.59 0.00 0.06 23.12 0.00 0.00 Others 738.65 263.05 326.85 992.39 -31.63 -540.58 -46.12 56.33 320.05 709.16 Cash from Financing Activity -737.08 -769.42 -561.50 -1,543.32 -524.24 -695.56 -427.62 -358.36 -306.63 -510.76 Net Cash Inflow / Outflow 563.20 474.68 29.23 -251.25 -119.00 300.38 6.03 -102.33 61.97 24.24 Opening Cash & Equivalents 538.85 64.17 34.94 286.19 405.19 104.81 98.78 201.10 139.13 114.89 Closing Cash & Equivalent 1,102.05 538.85 64.17 34.94 286.19 405.19 104.81 98.78 201.10 139.13

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 133.22 115.94 105.85 103.58 158.06 88.37 108.62 126.47 122.78 119.72 ROA 24.98% 24.97% 17.73% 15.70% 10.04% 9.53% 2.04% 5.53% 4.98% 7.08% ROE 47.94% 48.92% 32.96% 27.29% 18.04% 17.18% 5.53% 20.15% 17.14% 15.91% ROCE 65.81% 66.95% 45.85% 37.66% 37.15% 27.37% 16.51% 31.45% 26.36% 24.14% Fixed Asset Turnover 6.06 6.16 5.76 5.77 5.93 3.04 3.21 6.48 8.22 11.35 Receivable days 24.63 22.92 20.23 20.54 21.73 18.45 12.47 15.60 20.03 18.12 Inventory Days 38.91 43.54 46.48 49.10 53.51 58.87 54.87 57.56 58.34 57.72 Payable days 172.80 175.83 146.15 142.20 141.33 117.18 57.46 72.90 65.55 50.91 Cash Conversion Cycle -109.26 -109.37 -79.44 -72.56 -66.09 -39.85 9.88 0.26 12.81 24.94 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 505.80 950.96 450.79 460.68 389.70 129.34 51.90 1198.38 2865.01 2045.32

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 134.77 116.06 105.47 102.89 157.19 87.26 107.47 126.31 121.44 118.46 ROA 25.40% 25.15% 17.87% 15.76% 10.11% 9.52% 1.72% 5.77% 4.93% 5.16% ROE 48.76% 49.43% 33.43% 27.58% 18.39% 17.42% 4.71% 21.22% 17.26% 16.08% ROCE 66.79% 67.64% 46.49% 38.06% 37.72% 27.74% 15.76% 32.54% 26.56% 24.39% Fixed Asset Turnover 6.11 6.20 5.84 5.31 6.03 3.04 3.21 6.48 8.21 11.38 Receivable days 24.45 22.78 19.98 22.32 21.37 18.42 12.47 15.60 20.03 18.09 Inventory Days 40.60 44.57 47.50 55.82 54.91 60.14 54.88 57.56 58.36 57.89 Payable days 172.70 174.99 144.03 143.05 140.69 119.53 57.89 73.24 66.07 51.56 Cash Conversion Cycle -107.65 -107.65 -76.54 -64.91 -64.41 -40.97 9.45 -0.07 12.32 24.42 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 515.59 960.03 454.77 462.54 391.29 129.56 49.26 1232.59 2856.45 2045.74

Top Investors:

lici asm non par

investor education and protection fund (iepf)

Annual Reports:

News Update:

Glaxosmithkline Phar - Quarterly Results
4th Aug 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback